Identification, characterization and quantification of specific neuropeptides in rat spinal cord by liquid chromatography electrospray quadrupole ion trap mass spectrometry

Biomedical Chromatography

Volumn 23, Issue 9, 2009, Pages 940-950

  Beaudry, Francis ^a   Ferland, Catherine E ^a   Vachon, Pascal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Electrospray; Liquid chromatography; Mass spectrometry; Neurochemistry; Neuropeptides; Pain; Quantitative analysis

Indexed keywords

BIOCHEMISTRY; CHROMATOGRAPHIC ANALYSIS; LIQUID CHROMATOGRAPHY; PEPTIDES; RATS;

ELECTROSPRAYS; ION-TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY ELECTROSPRAY; NEUROCHEMISTRY; NEUROPATHIC PAIN; NEUROPEPTIDES; PAIN; QUADRUPOLE ION TRAPS; RAT SPINAL CORD; SUBSTANCE-P;

MASS SPECTROMETRY;

CALCITONIN GENE RELATED PEPTIDE; DYNORPHIN A; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FLOW RATE; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; SPINAL CORD; TANDEM MASS SPECTROMETRY;

ANIMALIA; RATTUS;

EID: 70349480988     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1206     Document Type: Article

References (39)

1. Abraham KE, McGinty JF and Brewer KL. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expresion and the onset of pain-related behavior following excitotoxic spinal cord injury. Neuroscience 2001; 104: 863-874.
2. Ai X, MacPhedran SE and Hall AK. Depolarization stimulates initial calcitonin gene-related peptide expression by embryonic sensory neurons in vitro. Journal of Neuroscience 1998; 18: 9294-9302.
3. Barber RP, Vaughn JE, Slemmon JR, Salvaterra PM, Roberts E and Leeman SE. The origin, distribution and synaptic relationships of substance P axons in rat spinal cord. Journal of Comparative Neurology 1979; 184: 331-352.
4. Beaudry F and Vachon P. Determination of substance P in rat spinal cord by high-performance liquid chromatography electrospray quadrupole ion trap mass spectrometry. Biomedical Chromatography 2006; 20: 1344-1350.
5. Beaudry F, Girard C and Vachon P. Early dexamethasone treatment following sciatic nerve cuff implantation decreases substance P in lumbar spinal cord of rats with neuropathic pain. Canadian Journal of Veterinary Research 2007; 71: 90-97.
6. Beaulieu P. Pharmacologie de la douleur. Les Presses de l'Université de Montréal: Montréal, 2005; 593.
7. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, van Ommen B and Smilde AK. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Analytical Chemistry 2006; 78: 567-574.
8. Bischoff R and Luider TM. Methodological advances in the discovery of protein and peptide disease markers. Journal of Chromatography B 2004; 803: 27-40.
9. Calvo KR, Liotta LA and Petricoin EF. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Bioscience Reports 2005; 25(1-2): 107-125.
10. Cañas B, Lopez-Ferrer D, Ramos-Fernandez A, Camafeita E and Calvo E. Mass spectrometry technologiers for proteomics. Briefings in Functional Genomics and Proteomics 2006; 4: 295-320.
11. Chavkin C, James IF and Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 1982; 215: 413-415.
12. Chen CH. Review of a current role of mass spectrometry for proteome research. Analytical Chemica Acta 2008; 624: 16-36.
13. Cho HJ and Basbaum AI. Increased staining of immunoreactive dynorphin cell bodies in the deafferented spinal cord of the rat. Neuroscience Letters 1988; 84: 125-130.
14. Civelli O, Douglass J, Goldstein A and Herbert E. Sequence and expression of the rat prodynorphin gene. Proceedings of the National Academy of Sciences of the United States of America 1985; 82: 4291-4295.
15. Cotter RJ, Griffith W and Jelinek C. Tandem time-of-flight (TOF/TOF) mass spectrometry and the curved-field reflectron. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2007; 855: 2-13.
16. Cravatt BF, Simon GM and Yates JR. The biological impact of mass spectrometry-based proteomics. Nature 2007; 450: 991-1000.
17. Dray A. Mechanism of action of capsaicin-like molecules on sensory neurons. Life Science 1992; 51: 1759-1765.
18. Dray A and Urban L. New pharmacological strategies for pain relief. Annual Review of Pharmacology and Toxicology 1996; 36: 253-280.
19. Fürst S. Transmitters involved in antinociception in the spinal cord. Brain Research Bulletin 1999; 48: 129-141.
20. Guerrera IC and Kleiner O. Application of mass spectrometry in proteomics. Bioscience Report 2005; 25(1-2): 71-93.
21. Guo A, Vulchanova L, Wang J, Li X and Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. European Journal of Neuroscience 1999; 11: 946-958.
22. Hökfelt T, Elde R, Johansson O, Luft R, Nilsson G and Arimura A. Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience 1976; 1: 131-136.
23. Hopfgartner G and Bourgogne E. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. Mass Spectrometry Review 2003; 22: 195-214.
24. Hu L, Ye M, Jiang X, Feng S and Zou H. Advances in hyphenated analytical techniques for shotgun proteome and peptidome analysis. Analytica Chemica Acta 2007; 598: 193-207.
25. Kajander KC, Sahara Y, Iadarola MJ and Bennett GJ. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides 1990; 11: 719-728.
26. Khalsa-Moyers G and McDonald WH. Developments in mass spectrometry for the analysis of complex protein mixtures. Briefings in Functional Genomics and Proteomics 2006; 5: 98-111.
27. Korfmacher WA. Principles and applications of LC-MS in new drug discovery. Drug Discovery Today 2005; 10: 1357-1367.
28. Kuraishia Y, Nanayamaa T, Ohnoa H, Minamia M and Satoh M. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neuroscience Letters 1988; 92: 325-329.
29. Malan TP, Ossipov MH, Gardell LR, Ibrahim M, Bian D, Lai J and Porreca F. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 2000; 86: 185-194.
30. Pitcher GM, Ritchie J and Henry JL. Nerve constriction in the rat: model of neuropathic, surgical and central pain. Pain 1999; 83: 37-46.
31. Ruda MA, Iadarola MJ, Cohen LV and Young WS. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proceedings of the National Academy of Sciences of the United States of America 1988; 85: 622-626.
32. Siddall PJ. Management of neuropathic pain following spinal cord injury: now and in the future. Spinal Cord 2008; 1-8 (published online November 11, 2008).
33. Tachibana T, Miki K, Fukuoka T, Arakawa A, Taniguchi M, Maruo S and Noguchi K. Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization. Journal of Neurotrauma 1998; 15: 485-494.
34. Vachon P, Massé R and Gibbs BF. Substance P and neurotensin are up-regulated in the lumbar spinal cord of animals with neuropathic pain. Canadian Journal of Veterinary Research 2004; 68: 86-92.
35. Weihe E, Millan MJ, Hollt V, Nohr D and Herz A. Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats. Neuroscience 1989; 31: 77-95.
36. Wood PL. The NMDA receptor complex: a long and winding road to therapeutics. IDrugs 2005; 8: 229-235.
37. Yaksh TL, Jessell TM, Gamse R, Mudge AW and Leeman SE. Nature 1980; 286(5769): 155-157
38. Yamamoto T and Yaksh TL. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Science 1991; 49: 1955-1963.
39. Zoorob RJ and Cender D. A different look at corticosteroids. American Family Physician, 1998; 58: 443-450.